According to the CEO of Sanofi, the group will bottle the Pfizer / BioNTech vaccine in its factory from July.
Sanofi helps Pfizer / BioNTech
Paul Hudson, CEO of Sanofi, announced that his laboratory would help Pfizer-BioNTech to more simply package its vaccine: “ We will use our factory in Frankfurt, Germany to package the product that will be supplied to us by Pfizer-BioNTech from July. As this production site is located near the BioNTech headquarters, this will make things easier. “.
” Our teams are working together to put things in place under the right conditions, because this is a much more complex procedure than it seems. Vialing of the vaccine should be done in a sterile environment and at very low temperature »He develops. Indeed, the vaccine developed by the pharmaceutical groups Pfizer and BioNTech has a difficult storage method, in particular because it must be stored at -70 ° C. In total, more than 100 million doses may be available by the end of the year, according to Paul Hudson. This production is intended for the European Union, part of which is for France.
A delay following disappointing results
Initially scheduled for the summer of 2021, the vaccine developed by the French pharmaceutical group Sanofi will be delayed, following disappointing clinical trials. Despite everything, research continues: ” We did not miss, we are late. If everything had gone well, we probably would have arrived in June-July, which would have been quite an achievement. That meant 15 months (compared to the start of the research), which is exceptional. We knew we would arrive after the others »Said Olivier Bogillot, president of Sanofi France. ” We had a dose problem during our trials, this happens in many clinical developments, it will delay us by a few months. »He emphasizes.
